Information
-
Trademark
-
79280356
-
Serial Number
79280356
-
Registration Number
6263411
-
International Classifications
-
Filing Date
November 14, 2019
5 years ago
-
Registration Date
February 09, 2021
3 years ago
-
Transaction Date
June 07, 2021
3 years ago
-
Status Date
February 09, 2021
3 years ago
-
Published for Opposition Date
November 24, 2020
4 years ago
-
Location Date
February 09, 2021
3 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
RENNEKER, CHRISTOPHER
-
Attorney Docket Number
061266.01010
Attorney Name
Manuel Valcarcel
Law Office Assigned Location Code
N30
-
Owners
Mark Drawing Code
3000
Mark Identification
MIDATECH PHARMA
Case File Statements
- CC0000: The color(s) blue is/are claimed as a feature of the mark.
- D10000: "PHARMA"
- DM0000: The mark consists of the wording "MIDATECH" in dark blue above the wording "PHARMA" in light blue. Next to the wording starts an incomplete circular array of light and blue dots that bend towards the letter "E" in "MIDATECH". White appearing in the mark is background and not claimed as a feature of the mark.
- GS0011: Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; nano-particle ingredients for use in pharmaceuticals, medicines and medicated cosmetics for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
- GS0051: Pharmaceutical preparations and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles
- GS0401: Custom manufacture of nano-particles for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
- GS0421: Scientific research services for others in the field of nano-particle technology; pharmaceutical and drug development and drug discovery services; scientific laboratory services, namely, testing, efficiency evaluation and advisory services in the field of nano-particles and nano-medicine; scientific laboratory services, namely, testing, efficiency and technical and scientific advisory services in the field of pharmaceuticals; scientific research laboratory services, namely, nano-particle laboratory services
Case File Event Statements
-
6/7/2021 - 3 years ago
30 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
5/12/2021 - 3 years ago
29 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
5/12/2021 - 3 years ago
28 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
5/9/2021 - 3 years ago
27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
2/9/2021 - 3 years ago
26 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
12/6/2020 - 4 years ago
25 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
11/24/2020 - 4 years ago
24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
11/24/2020 - 4 years ago
23 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/18/2020 - 4 years ago
22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
11/18/2020 - 4 years ago
21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
11/4/2020 - 4 years ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/16/2020 - 4 years ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/23/2020 - 4 years ago
18 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
9/23/2020 - 4 years ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/23/2020 - 4 years ago
16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
9/23/2020 - 4 years ago
15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
9/23/2020 - 4 years ago
14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Type: ECDR
-
9/23/2020 - 4 years ago
13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
9/23/2020 - 4 years ago
12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
9/23/2020 - 4 years ago
11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
9/23/2020 - 4 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/18/2020 - 4 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
3/28/2020 - 4 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
3/27/2020 - 4 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
3/17/2020 - 4 years ago
6 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
3/12/2020 - 4 years ago
5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
3/11/2020 - 4 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/11/2020 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/11/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
3/5/2020 - 4 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR